相关实验视频

Updated: Sep 9, 2025

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

用于增强药物输送的胆固醇功能化的多孔PLA微粒

Ahammed Hm Mohammed-Sadhakathullah^1,2, Leonor Resina^1,2, Hamidreza Enshaei^1,2

¹Innovation in Materials and Molecular Engineering - Biomaterials for Regenerative Therapies (IMEM-BRT) Group, Departament d'Enginyeria Química, EEBE, Universitat Politècnica de Catalunya, C/Eduard Maristany 10-14, Building I, second floor, Barcelona 08019, Spain.

ACS applied bio materials

|September 4, 2025

概括

我们开发了一种使用PEG-Chol的新型多孔乳酸药物输送系统. 这种先进的平台增强了抗癌药物的封装和释放,改善了乳腺癌的治疗.

科学领域:

生物材料科学
纳米技术
癌症治疗方法

背景情况:

传统的多乳酸 (PLA) 和多乳酸同糖化物 (PLGA) 纳米颗粒在药物封装和释放动力学方面存在局限性.
缺乏水溶性和系统性副作用阻碍了脂性抗癌药物的临床应用,如黄素和他莫西芬.
开发先进的药物输送系统对于改善癌症治疗疗效和患者治疗结果至关重要.

研究的目的:

开发和验证一种新型药物输送平台,使用透性聚乳酸 (PLA) 微粒与两性聚乙烯糖醇 (PEG-Chol) 功能化.
增强封装效率,并实现持续释放脂性抗癌剂.
改善针对性乳腺癌治疗的细胞相互作用和吸收.

主要方法:

使用PEG-Chol功能化的高度多孔的PLA微粒的制造.
囊括脂性抗癌剂,黄素 (Cur) 和他莫西芬 (Tmx).
使用MCF-7乳腺癌细胞进行体外评估,评估细胞吸收和细胞毒性.

主要成果:

与传统纳米颗粒相比,开发的混合系统证明了药物封装和持续释放的改善.
增强了PEG- 胆固醇的水性分散性,延长了血液循环,促进了细胞相互作用和内细胞分裂.
实验室研究证实细胞吸收成功,并显著降低了MCF-7乳腺癌细胞活力.

结论:

脂质功能化的多孔PLA颗粒代表了先进药物输送的有前途和多功能平台.
这种系统有效地解决了传统纳米颗粒在提供脂性抗癌药物的局限性.
经过验证的平台在乳腺癌治疗中具有显著的治疗潜力.

关键词:

泰莫西芬治疗乳腺癌的方法黄素聚乙烯糖醇-胆固醇聚乳酸微粒

更多相关视频

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

Synthesis and Characterization of Placental Chondroitin Sulfate A plCSA-Targeting Lipid-Polymer Nanoparticles

Synthesis and Characterization of Placental Chondroitin Sulfate A plCSA-Targeting Lipid-Polymer Nanoparticles

Published on: September 18, 2018

相关概念视频

Drug Delivery: Parenteral Route

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...